Nuveen, LLC Intra Cellular Therapies, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 304,125 shares of ITCI stock, worth $40.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
304,125Holding current value
$40.1 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
419Shares Held
77.9MCall Options Held
409KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$402 Million3.71% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$322 Million4.06% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...